Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, Mar 11 (Pulse News Wire) – Renascience Inc. (4889) announced a third-party allotment of stock warrants. KEY TERMS: - Warrants to be issued: 1,712 - Shares per warrant: 100 - Maximum dilution:
View all Renascience Inc. disclosures →
TOKYO, Mar 11 (Pulse News Wire) – Renascience Inc. (4889) announced a third-party allotment of stock warrants.
KEY TERMS: - Warrants to be issued: 1,712 - Shares per warrant: 100 - Maximum dilution: 171,200 shares - Gross proceeds: ¥523 million - Allocation date: 2026-03-26
🟡 Confidence: Standard AI-translated content.